Emmanuel Lim
Family Medicine · Los Angeles, CANPI 1275514234
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 458 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,469 and has fallen 89.8% since, to $354 in 2021. Among family medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Viiv Healthcare Company$1K
- Amgen$628
- EMD Serono, Inc.$553
- Novo Nordisk$547
- Johnson & Johnson$463
- plus $2K from 19 others
What the payments were for
- Food & beverage$7,052100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 68 | $1,285 |
| Viiv Healthcare Company | 108 | $1,200 |
| Amgen(2 entities) | 32 | $628 |
| EMD Serono, Inc. | 27 | $553 |
| Novo Nordisk | 38 | $547 |
| Johnson & Johnson | 35 | $463 |
| AstraZeneca | 23 | $450 |
| Sunovion Pharmaceuticals Inc. | 23 | $313 |
| Pfizer | 24 | $258 |
| Boehringer Ingelheim | 11 | $249 |
| AbbVie(2 entities) | 18 | $200 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $181 |
| Mylan Specialty L.p. | 7 | $136 |
| Lilly USA, LLC | 7 | $133 |
| Merck | 6 | $107 |
| Eisai Inc. | 4 | $79 |
| Kowa Pharmaceuticals America, Inc. | 1 | $58 |
| Mannkind Corporation | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Antares Pharma, Inc. | 2 | $32 |
| Scilex Pharmaceuticals Inc. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $18 |
| Mylan Institutional Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
How this compares
$7,052 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Los Angeles
- Pamela KushnerLos Angeles$1.2M
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Jacqueline KenneyLos Angeles$121K
- Sherly SoleimanEncino$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.